Longevity Apps and Platforms: The Five Categories
Five distinct product categories get discussed as one market, and matching the category to your actual gap matters more than choosing within a category.
The Short Answer
The longevity software market contains five distinct kinds of product doing five different jobs, and they get compared as if they were interchangeable. A wearable, a testing service, a supplement subscription, a coaching product and a record-keeping system solve different problems, and the useful question is which gap you actually have. Specific products, features and prices change continuously, so this covers the categories and the evaluation rather than a current ranking.
The Five Categories
Continuous monitoring devices. Wearables and continuous sensors. They measure behaviour and physiology between measurements, which is genuinely valuable, and their reliable outputs are narrower than their dashboards suggest: timing, activity, heart rate and their trends. Sleep staging and proprietary readiness scores are the weak parts.
Testing services. Blood panels, epigenetic tests, microbiome tests. They solve an access problem where routine care will not measure what you want, and their value depends on returning raw numbers from a named accredited laboratory.
Supplement subscription services. Recommend and supply products, usually based on a questionnaire and sometimes on testing. The structural issue is that the interpretation layer is not independent of the sales layer.
Coaching and behaviour products. Human or software coaching aimed at adherence, which is the variable that most determines outcomes and the one least addressed by everything else.
Record and decision systems. Consolidate measurements over time, check interactions, track changes and prompt review. The least marketed category and the one whose value compounds.
Most people buy from the first three and have gaps in the last two.
Matching Category to Gap
| Your actual problem | Category that addresses it |
|---|---|
| Do not know my apoB, Lp(a) or fasting insulin | Testing service |
| Do not know whether I am sleeping regularly or training enough | Continuous monitoring |
| Know what to do and do not do it | Coaching or behaviour product |
| Have a stack I cannot individually justify | Record and decision system |
| Results scattered across providers and years | Record and decision system |
| Taking medications alongside supplements | Interaction checking, in a decision system |
| Want someone to send me supplements | Subscription service, with the incentive caveat |
| Markers fine, feel unwell | None of the above; clinical assessment |
The third row is the largest gap in this market and the least served. The interventions with the strongest evidence are behavioural, adherence determines whether they happen, and almost no product in this space addresses adherence directly. Devices measure it and do not produce it.
The fourth and fifth rows are where most established users of this market actually are: enough data, enough purchases, and no structure holding it together.
What to Evaluate Within Any Category
Does it produce raw numbers with units? Applies to testing and monitoring alike. A proprietary score cannot be compared, tracked across providers, or read by a clinician.
Is the derivation of any composite published? Readiness, recovery, stress and biological age scores are frequently undisclosed functions with no independent validation.
Can you export your data, and delete it? The record is the asset that compounds, and if you cannot take it with you it belongs to the provider.
Does it ever recommend removing something, or nothing? The sharpest test of whether a system is evaluating or selling.
Does it ask about medications? Any product making supplement recommendations without this is skipping the highest-value safety function.
What is the review cadence it encourages? Daily engagement conflicts with the correct cadence, which is weekly for behavioural signals and quarterly for functional measures. A product optimising for daily use is optimising for retention.
What are the data terms? Retention, research consent, third-party sharing, and whether health data are used for purposes beyond the service.
Will you still be using it in five years? Continuity is the scarce input, and switching resets the accumulated record.
The Engagement Trap
Subscription products are optimised for retention, which is not the same as being optimised for your health, and the divergence is specific.
Daily engagement. A product needs you to open it daily; your health needs weekly trend review at most. Daily scores invite reacting to noise, which produces protocol churn and, for sleep specifically, can degrade the thing being measured.
Findings. A product needs to tell you something; the correct answer is frequently that nothing needs changing. A system that always finds something is not evaluating.
Additions. Subscription revenue grows with items shipped, and the correct action is often removal.
Novelty. New tests and new compounds sustain interest; the evidence-supported list is short and stable and does not.
Scores. A single improving number is satisfying and unfalsifiable; raw markers are less satisfying and interpretable.
None of this makes subscription products useless. It means the features that make a product engaging and the features that make it useful are partly in tension, and knowing which you are being sold is worth doing before subscribing.
What Nothing in This Market Provides
Adherence. The single largest determinant of outcomes, and no product produces it. Devices measure whether you trained; none makes you train.
Verification of slow outcomes. Whether your bone loading or apoB reduction changed your trajectory is not observable on any personal timescale, so no product can show it working.
Clinical care. Where a marker is markedly abnormal, a symptom is progressive or medication is indicated, consumer products should route to care and some do not.
Evidence that does not exist. Where a compound has thin trial data, no amount of platform sophistication resolves it.
The foundation. Sleep regularity, resistance training, aerobic volume, protein, blood pressure control and not smoking are free, unglamorous and account for most of the available benefit. No purchase substitutes for them, and buying any product in this market before they are in place is optimising the margin.
That last point is the honest centre of any comparison in this category, and it is worth applying before choosing between products rather than after.
A Sensible Allocation
If a budget exists, the ordering that follows from the evidence:
First, nothing. Establish the foundation. Free, and it is where most of the benefit is.
Second, a blood panel. Roughly twenty deliberately chosen analytes including apoB, lipoprotein(a) once and fasting insulin. Inexpensive, and it is the access problem worth solving.
Third, a blood pressure cuff, a tape measure and a grip dynamometer. Together they cost less than a month of most subscriptions and predict more than most of this market.
Fourth, a record. A spreadsheet is sufficient. Numbers with units, dates, conditions, in one place.
Fifth, a monitoring device if sleep regularity and activity volume are genuinely unknown to you.
Sixth, a decision system, if the stack has grown beyond what you can audit or you are on medications alongside supplements.
Seventh, coaching, if the gap is adherence, which for many people it is and which is rarely identified as the problem.
Supplement subscriptions do not appear on this list, which is deliberate. Buying specific compounds you have decided on is fine; subscribing to a service that decides for you and profits from the decision is the arrangement worth avoiding.
The AEONNN Perspective
AEONNN sits in the fifth category, a record and decision system, and this article is the honest description of what that category does and does not do. It consolidates measurements, checks interactions, tracks changes and prompts review, and its value compounds with duration rather than arriving on day one.
The gap the platform will not close is adherence. The interventions with the strongest evidence are behavioural, adherence determines whether they happen, and no product in this market produces it. A member whose foundation is not in place is better served by addressing that than by anything the platform offers, and the allocation above places nothing first for that reason.
The engagement trap is worth AEONNN naming against its own interest. Products need daily opening and health needs weekly trend review; products need to say something and the correct answer is frequently no change; subscription revenue grows with items shipped and the correct action is often removal. The platform's counter-signals are the ones the article proposes as tests: raw numbers rather than scores, published derivations, data export, medication checking, and a review cadence set by biology rather than retention.
Pillar Matrix mapping
Database Matrix layers
- Quality / Formulation Layer (ConsumerLab, Labdoor)
- Meta / Consensus Layer (JAMA, BMJ, specialty society positions)
- Real-Time User Layer (wearable and adherence signals)
- Evidence Layer (PubMed, Cochrane, ClinicalTrials.gov)
Frequently Asked
What categories of longevity product exist?
Continuous monitoring devices, testing services, supplement subscriptions, coaching and behaviour products, and record and decision systems. They solve different problems and get compared as if interchangeable.
Which category do most people need?
Most buy from the first three and have gaps in the last two. Scattered results with no structure, and a stack that cannot be individually justified, are the most common actual problems.
What is the largest unserved gap?
Adherence. The interventions with the strongest evidence are behavioural, adherence determines whether they happen, and devices measure it without producing it.
What should I evaluate in any product?
Whether it produces raw numbers with units, whether composite derivations are published, whether you can export and delete your data, whether it ever recommends removal, whether it checks medications, and its review cadence.
What is the engagement trap?
Products need daily opening while health needs weekly trend review, products need to say something while the correct answer is often no change, and subscription revenue grows with additions while removal is often correct.
What does nothing in this market provide?
Adherence, verification of slow outcomes, clinical care, evidence that does not exist, and the foundation of sleep, training, protein and blood pressure control.
How should a budget be allocated?
Foundation first at no cost, then a deliberate blood panel, then a cuff, tape measure and dynamometer, then a record, then a monitoring device if needed, then a decision system, then coaching if adherence is the gap.
Evidence and review
Any dosage ranges cited here reflect the ranges used in published human trials, not personal recommendations. Evidence in this field moves, so this article is reviewed quarterly and carries its last-updated date above. Nothing here is intended as medical advice, and supplementation should be discussed with a qualified clinician, particularly alongside prescribed medication or an existing condition.